Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 6, 1997

View Archived Issues

Abbott's newest dopaminergic compounds described in patent literature

5-HT4 antagonists disclosed by Taisho

Cephems in development at Meiji Seika

Cell migration inhibitors from Teijin

Japanese researchers develop new HIV protease inhibitors

Magainin analogues reported by Scripps

Pollakiuria treatment described by SS Pharm.

Tanabe Seiyaku discloses novel antinephritic compounds

Egis develops 5-LO inhibitors

Antitumor prodrugs for ADEPT from Pharmachemie

BTG describes immunosuppressive antibodies

BASF discloses antithrombotic from ticks

Lilly/Novo Nordisk discover candidate for IBS

Clinical trial data reported for meningitis vaccine

Another approval for first-line Abelcet

Hemosol discloses novel cellular immunotherapeutic procedure

Genzyme acquires PharmaGenics and forms new division

LifeTECH and Pall announce collaboration

Abgenix reports significant advance in human antibody technology

First Corlopam Renal Program study completed

Access/Dow collaborate on contrast agents and radiopharmaceuticals

Sugen's TK antagonist enters phase II

Antiobesity agent from Neurogen/Pfizer advances to multiple-dose trials

Whole-body hyperthermia therapy enters clinic for new indication

FDA approval for Ferring antifertility Rx

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...